All Stories

  1. Quantification of STLV-1 Tax in various tissues of non-human primates by different PCR methods
  2. Retroviral adapters hijack the RNA helicase UPF1 in a CRM1/XPO1-dependent manner and reveal proviral roles of UPF1
  3. Lyon, at the center of the global virology research challenge
  4. Peculiar transcriptional reprogramming with functional impairment of dendritic cells upon exposure to transformed HTLV-1-infected cells
  5. Peculiar transcriptional reprogramming with functional impairment of dendritic cells upon exposure to transformed HTLV-1-infected cells
  6. Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
  7. HTLV-1 biofilm polarization maintained by tetraspanin CD82 is required for efficient viral transmission
  8. Tetraspanin CD82 maintains HTLV-1 biofilm polarization and is required for efficient viral transmission
  9. STLV-1 Commonly Targets Neurons in the Brain of Asymptomatic Non-Human Primates
  10. Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses
  11. Un monde de virus
  12. Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors?
  13. Immunoprofiling of fresh HAM/TSP blood samples shows altered innate cell responsiveness
  14. Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread
  15. Renaud Mahieux (1968-2020)
  16. Microbial Biofilms: Human T-cell Leukemia Virus Type 1 First in Line for Viral Biofilm but Far Behind Bacterial Biofilms
  17. Letter to the Editor
  18. HTLV-1 infection of myeloid cells: from transmission to immune alterations
  19. STLV-1 as a model for studying HTLV-1 infection
  20. SQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-κB activation through its ubiquitin binding function
  21. HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact
  22. Sensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation
  23. Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases
  24. How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy
  25. HTLV-1 et cellules dendritiques
  26. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
  27. How does susceptibility to HTLV-1 infection varies with the maturation state of dendritic cells?
  28. Quand le cytosquelette d’actine fait le jeu des rétrovirus
  29. Correction: Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
  30. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
  31. Quantitative Analysis of Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection Using Co-Culture with Jurkat LTR-Luciferase or Jurkat LTR-GFP Reporter Cells
  32. Les cellules dendritiques folliculaires des ganglions stockent du VIH-1 infectieux malgré les traitements antirétroviraux
  33. Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication
  34. Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes
  35. Transmission intercellulaire de HTLV-1
  36. ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
  37. Alpha Interferon Restricts Human T-Lymphotropic Virus Type 1 and 2 De Novo Infection through PKR Activation
  38. Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines
  39. Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells
  40. Phosphoramidate Dinucleosides as Inhibitors of Hepatitis C Virus Subgenomic Replicon and NS5B Polymerase Activity
  41. 3′-Deoxy Phosphoramidate Dinucleosides as Improved Inhibitors of Hepatitis C Virus Subgenomic Replicon and NS5B Polymerase Activity
  42. Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation step
  43. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase
  44. The Crystal Structures of Chikungunya and Venezuelan Equine Encephalitis Virus nsP3 Macro Domains Define a Conserved Adenosine Binding Pocket
  45. Phosphoramidate Dinucleosides as Hepatitis C Virus Polymerase Inhibitors
  46. Comparative Virtual and Experimental Medium Throughput Screening for Hepatitis C Virus Polymerase Inhibitors
  47. The Imidazopyrrolopyridine Analogue AG110 Is a Novel, Highly Selective Inhibitor of Pestiviruses That Targets the Viral RNA-Dependent RNA Polymerase at a Hot Spot for Inhibition of Viral Replication
  48. Substituted Imidazopyridines as Potent Inhibitors of Hepatitis C Virus Replication that Target the Viral Polymerase
  49. The Imidazopyrrolopyridine Analogue AG110 is a Novel, Highly Selective Inhibitor of Pestivirus Replication and Targets the viral RNA-dependent RNA Polymerase
  50. General Catalytic Deficiency of Hepatitis C Virus RNA Polymerase with an S282T Mutation and Mutually Exclusive Resistance towards 2′-Modified Nucleotide Analogues
  51. Structural and Functional Basis for ADP-Ribose and Poly(ADP-Ribose) Binding by Viral Macro Domains
  52. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases
  53. Synthesis and Anti-BVDV Activity of Acridones As New Potential Antiviral Agents1
  54. A Novel, Highly Selective Inhibitor of Pestivirus Replication That Targets the Viral RNA-Dependent RNA Polymerase
  55. The modeled structure of the RNA dependent RNA polymerase of GBV-C Virus suggests a role for motif E in Flaviviridae RNA polymerases
  56. A Relaxed Discrimination of 2′-O-Methyl-GTP Relative to GTP between de Novo and Elongative RNA Synthesis by the Hepatitis C RNA-dependent RNA Polymerase NS5B
  57. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world
  58. Structural Analysis of the Activation of Ribavirin Analogs by NDP Kinase: Comparison with Other Ribavirin Targets
  59. Dimer stabilization upon activation of the transcriptional antiterminator LicT 1 1Edited by T. Richmond
  60. Sites of positive and negative regulation in the Bacillus subtilis antiterminators LicT and SacY
  61. Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study
  62. Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Nef Proteins Show Distinct Patterns and Mechanisms of Src Kinase Activation
  63. Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway
  64. The Human Immunodeficiency Virus Type 1 NEF Protein Binds the Src-Related Tyrosine Kinase Lck SH2 Domain Through a Novel Phosphotyrosine Independent Mechanism
  65. The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck
  66. Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses
  67. Physical and Functional Interaction of Nef with Lck
  68. Characterization of a Monoclonal Antibody Specific for the Ras-Related GTP-Binding Protein Rho A